TEVA Restructuring Thursday, September 3, 2026 0.00 Neutral

Teva amends deposit agreement to include mandatory exchange process

Teva Pharmaceutical Industries' depositary has amended the Second Amended and Restated Deposit Agreement, adding a mandatory cancellation and exchange process triggered by the termination of the ADR program or Company request. This action does not have an immediate financial market impact.

View original filing at SEC.gov →
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.

Get real-time financial news in your trading bot or app

GET FREE KEY — 10,000 calls/day